At the time of writing, Exelixis Inc [EXEL] stock is trading at $25.61, down -0.85%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EXEL shares have lost -0.47% over the last week, with a monthly amount glided 8.89%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on April 11, 2024, when Barclays downgraded its rating to a Equal Weight but kept the price target unchanged to $25 for it. Previously, BTIG Research started tracking the stock with Buy rating on December 19, 2023, and set its price target to $27. On December 15, 2023, Citigroup initiated with a Buy rating and assigned a price target of $31 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $28 on September 26, 2023. Oppenheimer reiterated its recommendation of a Outperform and raised its price target to $29 on August 22, 2023. SVB Securities started tracking with a Market Perform rating for this stock on August 08, 2023, and assigned it a price target of $18.
For the past year, the stock price of Exelixis Inc fluctuated between $18.64 and $27.53. Currently, Wall Street analysts expect the stock to reach $28 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $25.61 at the most recent close of the market. An investor can expect a potential return of 9.33% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
According to Exelixis Inc [NASDAQ:EXEL], the company’s sales were 2.01B for trailing twelve months, which represents an 35.61% jump. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.16 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.42 points at the first support level, and at 25.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.74, and for the 2nd resistance point, it is at 25.86.
Ratios To Look Out For
It is important to note that Exelixis Inc [NASDAQ:EXEL] has a current ratio of 4.27. Also, the Quick Ratio is 4.21, while the Cash Ratio stands at 0.46. Considering the valuation of this stock, the price to sales ratio is 3.63, the price to book ratio is 3.45 and price to earnings (TTM) ratio is 21.93.
Transactions by insiders
Recent insider trading involved Hessekiel Jeffrey, EVP, General Counsel & Sec, that happened on Aug 26 ’24 when 20000.0 shares were sold. Director, Freire Maria C completed a deal on Aug 14 ’24 to sell 8250.0 shares. Meanwhile, CSO/EVP Disc & Trans Research Aftab Dana sold 20883.0 shares on Aug 12 ’24.
